FTC, CVS Caremark and UnitedHealth
UnitedHealth, CVS Caremark, Express Scripts sued by FTC over skyrocketing insulin prices
The FTC sued UnitedHealth Group’s Optum unit, CVS Caremark and Cigna’s Express Scripts for allegedly steering diabetes patients towards higher priced insulin.
FTC sues drug middlemen over manipulating the insulin market
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in exchange for keeping lower-cost insulin off their lists of approved
FTC Sues CVS Health, Cigna And United Health Group For Inflating Insulin Prices
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's
UnitedHealth, Cigna, CVS PBMs targeted by FTC over inflated insulin prices
The Federal Trade Commission has brought an administrative complaint against three of the country's largest pharmacy benefit managers (PBMs), accusing them of engaging in practices that artificially inflated the list price of insulin drugs.
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
FTC Sues CVS, Cigna, UnitedHealth Over Rising Insulin Costs (1)
The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing the drug middlemen of engaging in illegal rebate programs that drove up the price of insulin.
UnitedHealth Vs. CVS Vs. Cigna: Which Health Stock Will Beat The FTC's Regulatory Heat?
Cigna may have the edge with smaller footprint and focused approach, but all three giants face risks from FTC's lawsuit over inflated insulin prices.
FTC sues CVS, Cigna, UnitedHealth over rising insulin prices
The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth (UNH) over insulin prices, claiming that they have been artificially inflating costs over the years.
FTC sues big 3 PBMs for ‘artificially inflated’ insulin prices caused by ‘perverse’ rebating
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to pay more for insulin.
FTC sues OptumRx, rivals over insulin pricing
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated ...
Drug middlemen illegally drive up the cost of insulin, FTC says
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.
Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the ...
IJR21h
Biden-Harris FTC Accuses Major Healthcare Companies Of Artificially Inflating Drug Prices In New Lawsuit
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...